3-methylidenyl-2-indolinone modulators of protein kinase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 15, 2005
Grant Date -
Feb 5, 2004
app pub date -
Mar 10, 2003
filing date -
Aug 5, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to novel 3-methylidenyl-2-indolinone compounds and physiologically acceptable salts and prodrugs thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully